Cargando…
Epigallocatechin gallate inhibits hepatitis B virus infection in human liver chimeric mice
BACKGROUND: Persistent hepatitis B virus (HBV) infection causes liver cirrhosis and hepatocellular carcinoma and constitutes a major worldwide health problem. Currently, anti-HBV drugs are limited to peginterferon and nucleos(t)ide analogs, which are costly and have considerable side effects; the de...
Autores principales: | Lai, Yu-Heng, Sun, Cheng-Pu, Huang, Hsiu-Chen, Chen, Jui-Chieh, Liu, Hui-Kang, Huang, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127945/ https://www.ncbi.nlm.nih.gov/pubmed/30189898 http://dx.doi.org/10.1186/s12906-018-2316-4 |
Ejemplares similares
-
Reduction of 3-Deoxyglucosone by Epigallocatechin Gallate Results Partially from an Addition Reaction: The Possible Mechanism of Decreased 5-Hydroxymethylfurfural in Epigallocatechin Gallate-Treated Black Garlic
por: Tu, An-Ting, et al.
Publicado: (2021) -
Epigallocatechin-3-Gallate Alleviates Liver Oxidative Damage Caused by Iron Overload in Mice through Inhibiting Ferroptosis
por: Yang, Chunjing, et al.
Publicado: (2023) -
Dietary Copper Reduces the Hepatotoxicity of (−)-Epigallocatechin-3-Gallate in Mice
por: Kaleri, Najeeb Ahmed, et al.
Publicado: (2017) -
Epigallocatechin gallate inhibits dimethylhydrazine-induced colorectal cancer in rats
por: Wang, Yu, et al.
Publicado: (2020) -
(−)-Epigallocatechin-3-Gallate Decreases Osteoclastogenesis via Modulation of RANKL and Osteoprotegrin
por: Chen, Shih-Tse, et al.
Publicado: (2019)